Financials in CAD. Standardized financial statements.
A compact view of how Andlauer Healthcare Group Inc. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $650.48M | $647.95M | $648.42M | $440.12M | $314.34M | $289.99M | $277.01M | $251.03M | $223.59M |
| Revenue Growth? | +0.4% | -0.1% | +47.3% | +40.0% | +8.4% | +4.7% | +10.3% | +12.3% | 0.0% |
| Cost of Revenue? | $503.27M | $500.47M | $489.58M | $329.36M | $234.79M | $221.90M | $214.46M | $196.64M | $172.46M |
| Gross Profit? | $147.20M | $147.48M | $158.85M | $110.75M | $79.55M | $68.08M | $62.55M | $54.39M | $51.13M |
| Gross Margin? | +22.6% | +22.8% | +24.5% | +25.2% | +25.3% | +23.5% | +22.6% | +21.7% | +22.9% |
| Operating Expenses? | $53.24M | $51.43M | $48.50M | $37.05M | $28.61M | $23.09M | $21.68M | $20.39M | $20.69M |
| Operating Income? | $93.96M | $96.05M | $110.34M | $73.70M | $50.94M | $44.99M | $40.87M | $33.99M | $30.44M |
| EBITDA? | $166.72M | $166.96M | $175.07M | $157.38M | $79.20M | $70.70M | $65.25M | $58.47M | $52.91M |
| Income Before Tax | $88.20M | $90.61M | $103.76M | $108.44M | $46.58M | $42.35M | $38.72M | $31.70M | $27.92M |
| Income Tax Expense | $23.73M | $24.47M | $27.48M | $18.49M | $8.87M | $12.00M | $10.53M | $8.52M | $7.44M |
| Net Income? | $64.47M | $66.14M | $76.28M | $89.95M | $37.71M | $29.77M | $26.72M | $21.68M | $19.15M |
| EPS? | $1.60 | $1.58 | $1.82 | $2.30 | $1.00 | $0.79 | $0.74 | $0.60 | $0.53 |
| Diluted EPS? | $1.58 | $1.55 | $1.79 | $2.25 | $0.98 | $0.79 | $0.74 | $0.60 | $0.53 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality